News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,077 Results
Type
Article (25902)
Company Profile (60)
Press Release (355115)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104301)
Career Advice (449)
Deals (16876)
Drug Delivery (51)
Drug Development (47589)
Employer Resources (47)
FDA (12260)
Job Trends (8441)
News (185967)
Policy (19423)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1749)
Accelerated approval (3)
Adcomms (8)
Allergies (70)
Alliances (26727)
ALS (55)
Alzheimer's disease (807)
Antibody-drug conjugate (ADC) (43)
Approvals (12315)
Artificial intelligence (160)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (46)
Brain cancer (17)
Breast cancer (180)
Cancer (1321)
Cardiovascular disease (111)
Career advice (407)
Career pathing (13)
CAR-T (66)
Cell therapy (191)
Cervical cancer (13)
Clinical research (40410)
Collaboration (422)
Compensation (124)
Complete response letters (9)
COVID-19 (1489)
CRISPR (11)
C-suite (130)
Cystic fibrosis (42)
Data (1421)
Decentralized trials (2)
Denatured (17)
Depression (28)
Diabetes (167)
Diagnostics (3509)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (51)
Drug pricing (53)
Drug shortages (21)
Duchenne muscular dystrophy (53)
Earnings (36828)
Editorial (19)
Employer branding (6)
Employer resources (44)
Events (51606)
Executive appointments (429)
FDA (13195)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (388)
Gene editing (35)
Generative AI (10)
Gene therapy (123)
GLP-1 (393)
Government (3027)
Grass and pollen (3)
Guidances (35)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (15)
Immunology and inflammation (38)
Indications (18)
Infectious disease (1558)
Inflammatory bowel disease (77)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (48)
Interviews (40)
IPO (7034)
IRA (19)
Job creations (1841)
Job search strategy (378)
Kidney cancer (7)
Labor market (9)
Layoffs (167)
Leadership (4)
Legal (3636)
Liver cancer (54)
Lung cancer (219)
Lymphoma (88)
Machine learning (2)
Management (17)
Manufacturing (99)
MASH (44)
Medical device (12873)
Medtech (12876)
Mergers & acquisitions (10121)
Metabolic disorders (413)
Multiple sclerosis (52)
NASH (11)
Neurodegenerative disease (46)
Neuropsychiatric disorders (9)
Neuroscience (1123)
NextGen: Class of 2025 (3930)
Non-profit (2820)
Northern California (1274)
Now hiring (16)
Obesity (213)
Opinion (69)
Ovarian cancer (50)
Pain (60)
Pancreatic cancer (52)
Parkinson's disease (87)
Partnered (11)
Patents (107)
Patient recruitment (71)
Peanut (37)
People (34665)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11580)
Phase II (17490)
Phase III (14376)
Pipeline (641)
Policy (57)
Postmarket research (1668)
Preclinical (3593)
Press Release (18)
Prostate cancer (70)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (178)
Real estate (2847)
Recruiting (16)
Regulatory (14165)
Reports (16)
Research institute (1606)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (47)
Series A (63)
Series B (45)
Service/supplier (3)
Sickle cell disease (21)
Southern California (1120)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (12)
Startups (2119)
Stomach cancer (8)
Supply chain (37)
Tariffs (7)
The Weekly (8)
United States (12210)
Vaccines (344)
Venture capitalists (13)
Weight loss (136)
Women's health (17)
Worklife (4)
Date
Today (59)
Last 7 days (265)
Last 30 days (1381)
Last 365 days (18632)
2025 (5106)
2024 (19849)
2023 (22737)
2022 (30682)
2021 (32995)
2020 (32198)
2019 (28415)
2018 (21811)
2017 (18912)
2016 (18128)
2015 (21205)
2014 (16038)
2013 (13253)
2012 (14369)
2011 (14631)
2010 (13203)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (116)
Arkansas (10)
Asia (24485)
Australia (3880)
California (2894)
Canada (1172)
China (343)
Colorado (158)
Connecticut (165)
Delaware (106)
Europe (47804)
Florida (517)
Georgia (124)
Idaho (33)
Illinois (349)
India (13)
Indiana (219)
Iowa (2)
Japan (109)
Kansas (72)
Kentucky (12)
Louisiana (6)
Maine (27)
Maryland (614)
Massachusetts (2034)
Michigan (104)
Minnesota (259)
Mississippi (2)
Missouri (51)
Montana (18)
Nebraska (18)
Nevada (30)
New Hampshire (59)
New Jersey (1080)
New Mexico (9)
New York (907)
North Carolina (539)
North Dakota (3)
Northern California (1274)
Ohio (124)
Oklahoma (3)
Oregon (23)
Pennsylvania (787)
Puerto Rico (7)
Rhode Island (23)
South America (520)
South Carolina (18)
Southern California (1120)
Tennessee (76)
Texas (508)
Utah (104)
Virginia (74)
Washington D.C. (38)
Washington State (218)
West Virginia (3)
Wisconsin (39)
381,077 Results for "teleflex medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teleflex Announces First Quarter 2025 Earnings Conference Call Information
April 17, 2025
·
1 min read
Press Releases
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
February 18, 2025
·
1 min read
Press Releases
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
October 29, 2024
·
7 min read
Press Releases
Teleflex Announces the Teleflex Center for Antimicrobial Protection
July 24, 2024
·
5 min read
Press Releases
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
November 19, 2024
·
1 min read
Pharm Country
Teleflex to Present at the BofA Securities 2024 Health Care Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT).
April 30, 2024
·
1 min read
Pharm Country
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of multiple clinical studies at the 2024 American Urological Association Annual Meeting, which is being held in San Antonio, TX, from May 3 – 6, 2024.
May 1, 2024
·
11 min read
Business
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024.
April 18, 2024
·
1 min read
Pharm Country
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).
February 20, 2024
·
1 min read
Press Releases
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
July 29, 2024
·
4 min read
1 of 38,108
Next
